FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

7388611000001108: Co-phenotrope 2.5mg/0.025mg tablets 20 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
23239701000001116 Co-phenotrope 2.5mg/0.025mg tablets 20 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
23239801000001113 Co-phenotrope 2.5mg/0.025mg tablets 20 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

3 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Is pack of Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Has active ingredient Diphenoxylate hydrochloride false Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Has active ingredient Atropine sulfate false Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Has active ingredient Difenoxin hydrochloride false Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Has VMP Product containing precisely atropine sulfate 25 microgram and diphenoxylate hydrochloride 2.5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Has specific active ingredient Atropine sulfate true Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Has specific active ingredient Diphenoxylate hydrochloride true Inferred relationship Existential restriction modifier
Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Co-phenotrope 2.5mg/0.025mg tablets (Part VIIID Drug Tariff Special Order) 20 tablet Is a True Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Inferred relationship Existential restriction modifier
Dymotil 2.5mg/25microgram tablets (Goldshield Healthcare Ltd) 20 tablet 2 x 10 tablets Is a True Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Inferred relationship Existential restriction modifier
Lofenoxal 2.5mg/25microgram tablets (Imported (Australia)) 20 tablet Is a True Co-phenotrope 2.5mg/0.025mg tablets 20 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start